Clinical trial
Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study
NCT00309712 · Intermountain Health Care, Inc., Other · Completed
Key facts
| NCT number | NCT00309712 |
|---|---|
| Title | Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study |
| Official title | Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study: A Randomized, Double-Blind Study of Simvastatin, Fenofibrate, and Combined Fenofibrate and Simvastatin in Patients With Controlled Type II Diabetics Without Evidence of Coronary Disease |
| Lead sponsor | Intermountain Health Care, Inc., Other |
| Collaborators | Abbott Industry Merck Sharp & Dohme LLC |
| Status | Completed |
| Study type | Interventional |
| Conditions | Type II Diabetes Mellitus, Mixed Dyslipidemia |
| Intervention type | Drug |
| Interventions | fenofibrate 160 mg and placebo, simvastatin 20 mg and placebo, fenofibrate 160 mg and simvastatin 20 mg |
| Enrollment | 300 |
| Start date | Aug 1, 2002 |
| Completion | Sep 1, 2006 |
| First posted | Apr 3, 2006 |
| Last update posted | Aug 21, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: